This archive covers milestones and breakthroughs from the scientific and academic world — researchers, universities, and institutions whose work advances human knowledge. Stories here highlight discoveries, studies, and scholarly efforts that point toward a better future.
Biotech researchers at the Chinese Academy of Sciences (CAS) say the new method could feed livestock much more efficiently than natural plants, while using a1/1000th as much land as farming.
For many years, research has focused on identifying novel therapies that stimulate beta-cell growth and function to restore insulin production in type 1 diabetics. Now, researchers at the Baker Heart and Diabetes Institute in Melbourne have brought us a step closer to making this a reality, regenerating damaged pancreatic cells so they can produce insulin and functionally respond to blood glucose levels. The novel therapeutic approach has the potential to become the first disease-modifying treatment for type 1 diabetes.
Following promising results from this recent trail, the combination of Moderna’s new mRNA-4157 and KEYTRUDA has been granted Breakthrough Therapy Designation by the FDA in the U.S., and accepted into the Priority Medicines scheme by the European Medicines Agency, for the treatment of high-risk melanoma.
A new study from Australia’s Murdoch University evaluating the effectiveness of an eight-week program focusing on self-compassion and mindfulness found that it reduced symptoms of post-traumatic stress and improved quality of life and connectivity in parts of the brain that regulate emotions.
Nuclear fusion just cleared a crucial bar: scientists at California’s Lawrence Livermore National Laboratory have now achieved ignition four separate times, with the best shot producing 89 percent more energy than the lasers delivered to the target. That repetition is what transforms a single 2022 breakthrough into real, replicable science — proof that the Sun-like reaction can be coaxed out of a frozen hydrogen pellet on Earth, again and again. Momentum is building beyond the lab, too, with more than $6 billion now invested in fusion worldwide and governments at COP28 agreeing to speed things along. The road from a boiled kettle’s worth of energy to a clean-powered grid is still long, but the hardest physics is finally behind us.
A new class of antibiotics has been discovered for the first time in more than 60 years, and artificial intelligence helped get us there. MIT researchers trained deep-learning models to sift through roughly 12 million chemical compounds, eventually landing on two promising candidates that each cut MRSA populations tenfold in mouse studies. Just as importantly, the team built their AI to be transparent, so scientists can actually see why certain molecules work. That matters because the same framework could be turned loose on other drug-resistant infections, offering real hope against superbugs that kill tens of thousands of people every year.
Researchers at the Massachusetts Institute of Technology exposed CO2 to catalysts and then electrolysis that turns the gas into a powder called sodium formate, which can be safely stored for decades. The breakthrough follows an almost century-long effort to turn CO2 into a cheap, clean fuel. Researchers have previously turned CO2 into fuels that required too much energy to make or were difficult to store long-term.
New research from Maryland-based Sunstone Therapies found that psilocybin-assisted therapy for cancer patients induced a clinically meaningful improvement in depression symptoms, with 80% of participants demonstrating a sustained response and 50% showing full remission of depression symptoms at week one, which was sustained for eight weeks.
A new breast cancer vaccine sparked an immune response in three out of four patients during its first human safety trial — with no serious side effects reported. The Cleveland Clinic study targeted triple-negative breast cancer, an aggressive subtype that resists most standard treatments and disproportionately affects younger women and Black women. The vaccine works by training the immune system to recognize a lactation protein found in most TNBC tumors but absent in healthy adult tissue, giving immune cells a clear target. Next come larger trials testing whether it can prevent recurrence and even attack active tumors. It’s an early but hopeful signal in the growing field of cancer immunotherapy, where teaching the body to find cancer itself is reshaping what treatment can look like.
Fusion energy just took a real step forward in Japan: JT-60SA, the largest experimental fusion reactor on Earth, has officially powered up in Ibaraki Prefecture. Standing six stories tall, it heats plasma to roughly 200 million degrees Celsius — hotter than the sun’s core — to study the same process that lights the stars. More than 500 scientists and 70 companies across Japan and the European Union built it together, and its job is to pave the way for ITER, the even larger reactor rising in France. Fusion still has a long road ahead, but moments like this remind us what becomes possible when nations pool decades of expertise toward a shared, emissions-free future.
